Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Martin

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Neuroscience Letters|September 30, 1985
Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist?R Gerber, B J Barbaz, L L Martin, et al.
Diabetologia|September 1, 1992
Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular functionJ N Harvey, A W Edmundson, A A Jaffa, et al.
Journal of Medicinal Chemistry|May 1, 1981
Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 6. Synthesis, 13C NMR, and biological evaluation of cis- and trans-4-amino-3'-arylspiro[cyclohexane-1,1'(3'H)-isobenzofuran] derivativesL L Martin, M Worm, M N Agnew, et al.
Journal of Medicinal Chemistry|November 1, 1979
Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 5. Conformationally mobile analogues derived by furan ring openingL L Martin, S S Klioze, M Worm, et al.
Journal of Medicinal Chemistry|April 1, 1982
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 2. Nuclear-substituted analogues of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and (+/-)-4,5-dihydro-2-ethyl-3-methyl-4-phenyl-3H-1,3-benzodiazepine as potential antidepressant agentsL L Martin, L L Setescak, M Worm, et al.
Clinical Pharmacology and Therapeutics|April 1, 1991
Pharmacokinetics of CGS 12970 and inhibition of thromboxane synthesis after oral administration in healthy adultsL L Martin, A V Schaffer, A Piraino, et al.
Neuropharmacology|July 1, 1988
Constant infusion of [13C6]glucose: simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animalsP L Wood, H S Kim, D L Cheney, et al.
Clinical Pharmacology and Therapeutics|December 1, 1992
Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipientsM L Chouinard, L L Martin, T Coffman, et al.
Journal of Medicinal Chemistry|April 1, 1982
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 1. Synthesis and evaluation of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and analogues as potential antidepressant agentsH M Geyer, L L Martin, C A Crichlow, et al.
The Journal of Antibiotics|May 1, 1981
The biosynthesis of the antibiotic pyrrolnitrin by Pseudomonas aureofaciensC J Chang, H G Floss, D J Hook, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Neuroscience Letters|September 30, 1985
Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist?R Gerber, B J Barbaz, L L Martin, et al.
Diabetologia|September 1, 1992
Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular functionJ N Harvey, A W Edmundson, A A Jaffa, et al.
Journal of Medicinal Chemistry|May 1, 1981
Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 6. Synthesis, 13C NMR, and biological evaluation of cis- and trans-4-amino-3'-arylspiro[cyclohexane-1,1'(3'H)-isobenzofuran] derivativesL L Martin, M Worm, M N Agnew, et al.
Journal of Medicinal Chemistry|November 1, 1979
Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 5. Conformationally mobile analogues derived by furan ring openingL L Martin, S S Klioze, M Worm, et al.
Journal of Medicinal Chemistry|April 1, 1982
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 2. Nuclear-substituted analogues of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and (+/-)-4,5-dihydro-2-ethyl-3-methyl-4-phenyl-3H-1,3-benzodiazepine as potential antidepressant agentsL L Martin, L L Setescak, M Worm, et al.
Clinical Pharmacology and Therapeutics|April 1, 1991
Pharmacokinetics of CGS 12970 and inhibition of thromboxane synthesis after oral administration in healthy adultsL L Martin, A V Schaffer, A Piraino, et al.
Neuropharmacology|July 1, 1988
Constant infusion of [13C6]glucose: simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animalsP L Wood, H S Kim, D L Cheney, et al.
Clinical Pharmacology and Therapeutics|December 1, 1992
Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipientsM L Chouinard, L L Martin, T Coffman, et al.
Journal of Medicinal Chemistry|April 1, 1982
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 1. Synthesis and evaluation of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and analogues as potential antidepressant agentsH M Geyer, L L Martin, C A Crichlow, et al.
The Journal of Antibiotics|May 1, 1981
The biosynthesis of the antibiotic pyrrolnitrin by Pseudomonas aureofaciensC J Chang, H G Floss, D J Hook, et al.
Pageof 7